DONATE

IBEC scientist César Rodriguez-Emmenegger awarded prestigious ERC Consolidator Grant

IBEC’s Principal Investigator César Rodriguez-Emmenegger has been awarded an ERC Consolidator Grant. This prestigious European funding supports scientists in the consolidation phase of their research teams, allowing them to pursue innovative scientific ideas. The €2 million over five years will allow Rodriguez-Emmenegger and his team to develop Phagocytic Synthetic Cells (PSCs) to fight antibiotic-resistant pathogens.

Three IBEC researchers selected in the CaixaResearch 2024 call to lead health research projects

IBEC researchers Benedetta Bolognesi, Xavier Fernàndez Busquets and Xavier Trepat have been selected in the CaixaResearch 2024 call to lead their own research projects. The grants will provide financial support for the scientists to carry out their research in key areas such as cancer, malaria and amyotrophic lateral sclerosis.

Marina Giannotti and Nina Kostina receive the BIST Mothers of Science Grant

The IBEC senior researchers were two of the winners of the fourth edition of the call for applications. Through this initiative, BIST recognises and supports scientist mothers working to reach a leading position and advance the research in their fields.

Pere Roca-Cusachs receives ICREA Acadèmia program distinction for the second time

IBEC researcher Pere Roca-Cusachs has been awarded the “ICREA Academia” distinction by the Catalan Institution for Research and Advanced Studies (ICREA). The leader of IBEC’s Cellular and Molecular Mechanobiology group received the award in the Life & Medical Sciences category.

Benedetta Bolognesi awarded a prestigious European ERC Consolidator Grant

The researcher at the Institute for Bioengineering of Catalonia has been awarded an ERC Consolidator Grant. This prestigious European funding supports excellent scientists and scholars who are consolidating their independent research teams to pursue their most promising scientific ideas. The €2 million grant over 5 years will allow Bolognesi and her team to develop a new method for identifying mutations that lead to the formation of amyloids—aggregates of proteins that contribute to a variety of diseases, including Alzheimer’s and Parkinson’s.